Oncology is a branch of medicine that deals specifically with the treatment of cancer. Oncology pharmaceuticals market is a leading segment of the overall pharmaceuticals market in view of the fact that cancer is the leading cause of mortality in the world and that is why market is characterized by a huge demand for cancer drugs. 

Oncology Industry Current Trends

• Cancer therapies to achieve collective sales of $37.2bn by 2014 in the seven major markets (namely US, Japan, France, Germany, Italy, Spain, and the UK), growing at a Compound Annual Growth Rate (CAGR) of 7.36% from 2011 to 2014. according to DataMonitor
• Global Oncology therapeutics market was valued at $33.3 billion in 2010, increasing from $12.8 billion in 2002 to $33.3 billion at a CAGR of 12.7% during the review period 2002–2010. The market is projected to witness moderate growth of 5.7% during the forecast period 2010–2017, to reach $48.9 billion in 2017 according to GBI Research
• Global Cancer Generic Drugs Market to Post 26% CAGR in 2011-2015 as per RNCOS

Major Oncology Therapeutics Market Players

Some of the top players in the Oncology Therapeutics industry are : Johnson & Johnson, Pfizer, Novartis, Abbott Laboratories, Merck, Wyeth, Bristol-Meyers Squibb, Eli Lilly, Amgen, Schering-Plough, Boston Scientific, Biogen Idec.